These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 15936170
1. Chemo-radiotherapy versus radiotherapy alone in the pre-operative treatment of resectable rectal cancer. Goethals L, Haustermans K, Perneel C, Bussels B, D'Hoore A, Geboes K, Ectors N, Van Cutsem E, Van den Bogaert W, Penninckx F. Eur J Surg Oncol; 2005 Nov; 31(9):969-76. PubMed ID: 15936170 [Abstract] [Full Text] [Related]
2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM). Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206 [Abstract] [Full Text] [Related]
3. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy. Lindebjerg J, Spindler KL, Ploen J, Jakobsen A. Colorectal Dis; 2009 Mar 15; 11(3):264-9. PubMed ID: 18573119 [Abstract] [Full Text] [Related]
4. [Prognostic factors and outcome of esthesioneuroblastoma]. Zhao LJ, Gao L, Xu GZ, Li SY, Xiao GL. Zhonghua Zhong Liu Za Zhi; 2005 Sep 15; 27(9):561-4. PubMed ID: 16438858 [Abstract] [Full Text] [Related]
5. Short versus conventional preoperative radiotherapy of rectal cancer: indications. Klenova A, Georgiev R, Kurtev P, Kurteva G. J BUON; 2007 Sep 15; 12(2):227-32. PubMed ID: 17600877 [Abstract] [Full Text] [Related]
6. Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes in a randomized trial. Bujko K, Michalski W, Kepka L, Nowacki MP, Nasierowska-Guttmejer A, Tokar P, Dymecki D, Pawlak M, Lesniak T, Richter P, Wojnar A, Chmielik E, Polish Colorectal Study Group. Int J Radiat Oncol Biol Phys; 2007 Feb 01; 67(2):369-77. PubMed ID: 17118570 [Abstract] [Full Text] [Related]
7. Preoperative chemoradiation therapy for low rectal cancer. Impact on downstaging and sphincter-saving operations. Habr-Gama A, Perez RO, Kiss DR, Rawet V, Scanavini A, Santinho PM, Nadalin W. Hepatogastroenterology; 2004 Feb 01; 51(60):1703-7. PubMed ID: 15532809 [Abstract] [Full Text] [Related]
8. Preoperative radio/chemo-radiotherapy in combination with intraoperative radiotherapy for T3-4Nx rectal cancer. Sadahiro S, Suzuki T, Ishikawa K, Fukasawa M, Saguchi T, Yasuda S, Makuuchi H, Murayama C, Ohizumi Y. Eur J Surg Oncol; 2004 Sep 01; 30(7):750-8. PubMed ID: 15296989 [Abstract] [Full Text] [Related]
9. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation. Díaz-González JA, Calvo FA, Cortés J, García-Sabrido JL, Gómez-Espí M, Del Valle E, Muñoz-Jiménez F, Alvarez E. Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1122-8. PubMed ID: 16406393 [Abstract] [Full Text] [Related]
10. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer. Kim JC, Takahashi K, Yu CS, Kim HC, Kim TW, Ryu MH, Kim JH, Mori T. Ann Surg; 2007 Nov 15; 246(5):754-62. PubMed ID: 17968166 [Abstract] [Full Text] [Related]
13. Long-term results of intraoperative presacral electron boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and chemoradiation in patients with locally advanced rectal cancer. Krempien R, Roeder F, Oertel S, Roebel M, Weitz J, Hensley FW, Timke C, Funk A, Bischof M, Zabel-Du Bois A, Niethammer AG, Eble MJ, Buchler MW, Treiber M, Debus J. Int J Radiat Oncol Biol Phys; 2006 Nov 15; 66(4):1143-51. PubMed ID: 16979835 [Abstract] [Full Text] [Related]
14. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy. Liersch T, Langer C, Ghadimi BM, Kulle B, Aust DE, Baretton GB, Schwabe W, Häusler P, Becker H, Jakob C. J Clin Oncol; 2006 Sep 01; 24(25):4062-8. PubMed ID: 16943523 [Abstract] [Full Text] [Related]
16. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy. Valentini V, Coco C, Minsky BD, Gambacorta MA, Cosimelli M, Bellavita R, Morganti AG, La Torre G, Trodella L, Genovesi D, Portaluri M, Maurizi-Enrici R, Barbera F, Maranzano E, Lupattelli M. Int J Radiat Oncol Biol Phys; 2008 Feb 01; 70(2):403-12. PubMed ID: 17919844 [Abstract] [Full Text] [Related]
17. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose. Lee SH, Lee KC, Choi JH, Oh JH, Baek JH, Park SH, Shin DB. Jpn J Clin Oncol; 2008 Feb 01; 38(2):112-21. PubMed ID: 18263881 [Abstract] [Full Text] [Related]
18. A prospective, randomized trial of pre-operative and intraoperative radiotherapy versus surgery alone in resectable gastric cancer. Skoropad VY, Berdov BA, Mardynski YS, Titova LN. Eur J Surg Oncol; 2000 Dec 01; 26(8):773-9. PubMed ID: 11087644 [Abstract] [Full Text] [Related]